MARSHALL WACE, LLP

Position in HUMA — Humacyte, Inc.

CIK 1318757 LONDON, X0

Position in HUMA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$141,827

-$327,494 QoQ

Shares Held

181,831

-62.8% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 163 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. HUMA ranks #251 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$141,827	181,831	-62.8%	Shares	Other	2026-08-13
2025-12-31	$469,321	488,369	-40.4%	Shares	Other	2026-02-13
2025-09-30	$1,424,979	818,954	-69.0%	Shares	Other	2025-11-13
2025-06-30	$5,515,915	2,639,194	+5308.2%	Shares	Other	2025-08-13
2025-03-31	$83,204	48,800	-11.1%	Shares	Other	2025-05-15
2024-12-31	$277,330	54,917	-90.6%	Shares	Other	2025-02-13
2024-09-30	$3,180,017	584,562	+26.1%	Shares	Other	2024-11-14
2024-06-30	$2,225,577	463,662	+3301.5%	Shares	Other	2024-08-14
2024-03-31	$42,392	13,631	-91.3%	Shares	Other	2024-05-15
2023-12-31	$446,334	157,160	-10.8%	Shares	Other	2024-02-14
2023-09-30	$516,286	176,207	-8.5%	Shares	Other	2023-11-14
2022-09-30	$627,647	192,530	+227.3%	Shares	Other	2022-11-14
2022-06-30	$188,837	58,828	—	Shares	Other	2022-08-15
No filing history on record for this holder in this stock.